Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Intralesional triamcinolone is more effective than the Excimer laser for treating localized alopecia areata.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Finasteride and dutasteride both improve hair growth effectively, but dutasteride has stronger anti-androgen effects and finasteride may cause more sexual side effects.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

More severe hair loss is linked to more sexual dysfunction in both men and women.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

The instruments are valid but don't fully capture the emotional impact on adolescents with alopecia areata.

Vitamin D levels are not linked to alopecia areata.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Higher sulfotransferase enzyme levels predict better response to minoxidil for hair growth.

The SULT1A1 enzyme booster improves minoxidil effectiveness in treating hair loss, especially in females.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

Computational techniques can improve drug development for treating certain conditions.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.